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DObjective:Mitral valve repair for anterior mitral leaflet prolapse is technically challenging. We report here our
experience with minimally invasive anterior mitral leaflet repair.
Methods: Our institutional database for minimally invasive mitral valve surgery was screened for patients with
mitral regurgitation caused by isolated prolapse of the anterior mitral leaflet. Patient characteristics, intraoper-
ative data, and short- and long-term outcomes are analyzed and reported.
Results:A total of 180 patients presented with mitral regurgitation caused by isolated anterior mitral leaflet pro-
lapse. All patients underwent minimally invasive surgery at our institution between 1999 and 2010. Mitral valve
repair was performed in 170 cases (94.4%), and these patients form the focus of this study. The mean age of the
patients was 59.7 14.8, and their mean log EuroSCORE was 4.9 5.1. Mean aortic crossclamp time (cardio-
pulmonary bypass time) was 82 25 minutes (130 40 minutes). Mitral valve repair techniques were neochor-
dal replacement with the loop technique in 68.2% of patients, chordal transfer in 14.7%, anterior mitral leaflet
resection in 7.1%, and edge-to-edge repair in 5.9%. Thirty-day mortality was 1.8%. Kaplan-Meier estimates
showed 86.7%  3.2% survival and 95.7%  1.6% freedom from mitral valve reoperation at 5 years.
Conclusions: This large series demonstrates good results for anterior mitral leaflet repair with the minimally
invasive approach. (J Thorac Cardiovasc Surg 2013;146:109-13)Mitral valve (MV) repair for anterior mitral leaflet (AML)
prolapse is technically challenging. Several repair strategies
are available; however, leaflet resection and implantation of
neochordae are reported to be of especial value.1-5
Nevertheless, these repair techniques are not exclusive,
and a large variety of repair techniques have proved to
have acceptable long-term results.6-15
Our institutional policy for MV repair in cases of AML
prolapse is to use chordal replacement by the loop technique
through a minimally invasive approach.12,16 We report here
on the repair strategies and long-term outcomes in patients
with isolated AML prolapse undergoing minimally invasive
MV surgery.MATERIALS AND METHODS
Between September 1999 and May 2010, a total of 180 patients under-
went surgery for isolated AML prolapse at our institution through a mini-
mally invasive technique. Indication for MV surgery was moderate or
severe mitral regurgitation (MR) as a result of AML prolapse, with either
symptoms of heart failure, signs of left ventricular dysfunction, or dilation
of the left ventricle. Patients with prolapse of the posterior mitral leaflet,
those with previous cardiac surgery, and those undergoing concomitant tri-
cuspid valve surgery were excluded from this study.he Department of Cardiac Surgery, University of Leipzig Heart Center,
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The Journal of Thoracic and CaMV repair was successfully performed in 170 patients (94.4%), and
these form the focus of this study. In the remaining 10 patients (5.9%),
MVreplacementwas necessary, in 1 case after a failed repairwith goodpost-
operative outcome. Predominant MV pathologies according to MV repair
versus replacement are depicted in Figure 1.MV replacement was indicated
in patients with significant sclerosis of theMVannulus and leaflets, whereas
annular dilatation was present in most patients who underwent MV repair.
The study was approved by the local ethics committee, Preoperative, in-
traoperative, and postoperative characteristics of patients were prospec-
tively entered into our institutional database and retrospectively
analyzed. In addition, preoperative and predischarge echocardiographic re-
ports were collected and analyzed. MR was calculated by measurement of
vena contracta (VC) in a 4-chamber view.17 TheMR gradingwas defined as
follows: none (VC of 0), mild (VC<3 mm), moderate (VC of 3-6.9 mm),
and severe (VC 7 mm).18
Surgical Technique
MV surgery was performed through a 5- to 8-cm right anterolateral min-
ithoracotomy in the 4th or 5th intercostal space, as previously described
elsewhere.12,14,19 The Chitwood clamp was used for aortic occlusion.20
Transesophageal echocardiography was routinely performed for assess-
ment of MV anatomy and function and for evaluation of left ventricular
function before and after MV repair.
All but 2 patients (1.2%) received a MV ring annuloplasty with either
a complete rigid ring (90.0%; n ¼ 153) or an incomplete flexible band
(8.8%; n ¼ 15).
The technique chosen to correct the AML prolapse was at the surgeon’s
discretion. Most patients (n¼ 116; 68.2%) underwent implantation of neo-
chordae by the loop technique, which has been well described
elsewhere.15,16
Follow-up
Individual patient contact after discharge was performed by sending
questionnaires to all patients annually. Patients who did not respond
were contacted by phone call. In case no further information was available,
family physicians were contacted. Follow-up was 94% complete, with
a mean follow-up time of 4.3  2.9 years (range, 1 day-11.8 years).rdiovascular Surgery c Volume 146, Number 1 109
Abbreviations and Acronyms
AML ¼ anterior mitral leaflet
CI ¼ confidence interval
MR ¼ mitral regurgitation
MV ¼ mitral valve
VC ¼ vena contracta
Acquired Cardiovascular Disease Pfannm€uller et al
A
C
DStatistical Analysis
Continuous variables are expressed as mean  SD, and categoric data
are expressed as proportions. Cumulative survival was calculated by
Kaplan-Meier methods. All statistical analyses were performed with the
SPSS statistical software package (version 17.0; IBM Corporation, Ar-
monk, NY).RESULTS
Average patient age was 69.7  14.8 years for the entire
patient cohort, and 57% of the patients were male. Average
preoperative New York Heart Association functional class
was 2.3  0.9. Mean preoperative left ventricular function
was 61.2%  11.9%, with 34% of the patients presenting
with atrial fibrillation and most having hypertension. Thir-
teen patients (7.7%) had previously undergone pacemaker
or automatic implantable cardioverter/defibrillator implan-
tation (Table 1).
Isolated MV repair was performed in 113 patients
(66.5%). Concomitant procedures included ablation for
atrial fibrillation in 27.1% of the cases and closure of an
atrial septal defect or patent foramen ovale in 10.6%.
Operation time averaged 176  50 minutes for all pa-
tients, with an aortic crossclamp time of 82  25 min and
a cardiopulmonary bypass time of 131  41 minutes. In 1
case (0.6%), conversion to sternotomy was required for
bleeding originating from the pulmonary artery caused by
the transthoracic aortic crossclamp.
The average implanted ring size was 31.0  5.3 mm for
all patients. Avariety ofMV repair techniques were used, as
shown in Figure 2. Chordal resuspension of the AML with
the loop technique was performed in 68.5% of the cases
(Table 2).
Three patients (1.8%) had postoperative stroke, and a to-
tal of 3 patients (1.8%) had low cardiac output syndrome
develop. Postoperative bleeding necessitating rethoracot-
omy occurred in 10 patients (5.9%). The bleeding source
was identified in 3 cases at a small-caliber blood vessel in
the intercostal space and in 2 cases at the atriotomy site.
In the remaining 5 cases, no identification of the origin of
bleeding was achieved.
Preoperative echocardiography confirmed moderate MR
(defined as VC>3mm and<7mm) in 77.3% of the patients
(129/167) and severe MR (VC 7 mm) in the remaining
patients. Postoperative predischarge MR was graded as
none in 65.7% of the cases (95/143), as trace in 31.2%110 The Journal of Thoracic and Cardiovascular Surg(44/143), and as moderate in 3.6% (5/143). In 141 patients
(83%), preoperative and predischarge echocardiographic
imaging was available for a correlation, which is shown
in Figure 3. There was no significant difference in predis-
charge MR grading between patients undergoing repair
with versus without the loop technique (P ¼ .5).
Eleven patients required late reoperation, 8 for MV-
related causes. Reason for MV-related reoperation was re-
current MR in 6 patients: in 4 of these patients as a result
of ring dehiscence, in 1 patient because of occlusion of
the circumflex artery, and in 1 patient because of injury of
the aortic valve from MV suture placement. Reoperations
for causes not related to the MV occurred in 3 cases: 2
patients underwent subsequent heart transplant, and 1 un-
derwent isolated tricuspid valve repair. Freedom from
MV-related reoperation at 5 years was 95.7%  1.9%
(95% confidence interval [CI] for mean survival time/
mean time of freedom from reoperation, 126.9-138.7
months; Figure 4).
Overall 30-day mortality was 1.8% (3 patients). One pa-
tient died of acute aortic dissection 6 days after surgery and
an initially uneventful postoperative course. One patient
had acute lung failure develop, and the remaining patient
died of low-output postcardiotomy syndrome (preoperative
left ventricular ejection fraction, 15%).
There were 15 late deaths. Reasons for death were carci-
noma in 2 patients (63 and 64 years old), gastrointestinal
bleeding in 1 patient (79 years old), pneumonia with sepsis
in 1 patient (41 years old), cardiac-related cause in 1 patient
(preoperative left ventricular ejection fraction 15%, 49
years old), and unknown in 10 patients.
Overall 5-year survival was 88.2%  3.0% (95% CI,
115.0-130.7 months). There was no survival difference
at 5 years with respect to the use of the loop technique,
with a survival of 88.8%  3.8% (95% CI, 106.0-135.7
months) with the technique versus 83.8%  5.7% (95%
CI, 107.5-131.6 months) without it (Figure 5).
DISCUSSION
In this study, we have demonstrated the feasibility and
safety of MV repair of AML prolapse through a minimally
invasive technique. A high freedom from MV-related reop-
eration was achieved.
Several investigators have demonstrated the value of
polytetrafluoroethylene sutures for chordal replacement
in the treatment of AML prolapse, with promising long-
term results. Frater and colleagues4 initiated the use of pol-
ytetrafluoroethylene sutures for chordal replacement in
1983. This approach was taken up and modified by David
and colleagues,1 who reported their initial experience with
polytetrafluoroethylene chordal replacement in 1989. The
latter group later demonstrated an excellent 10-year free-
dom from MV-related reoperation of 96%  1% among
patients with myxomatous disease with and withoutery c July 2013
FIGURE 1. Mitral valve pathology in patients undergoing mitral valve
repair or replacement. AML, Anterior mitral leaflet; PML, posterior mitral
leaflet.
FIGURE 2. Methods of mitral valve repair. AML, Anterior mitral leaflet.
TABLE 2. Length and number of implanted polytetrafluoroethylene
loops for chordal replacement
No. of loops
P
value
Loop length
(mm)
P
value
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Dpolytetrafluoroethylene chordal replacement and con-
cluded that polytetrafluoroethylene chordal replacement
was associated with no observable adverse effects on the
probability of MV repair success.21 In 2005, the same
group reported a freedom from severe recurrent MR rate
of 86% at 12 years after MV repair for AML prolapse
and an 88%  4% freedom from MV-related reoperation.7
Approximately three quarters of these patients were treated
with polytetrafluoroethylene chordal replacement, results
that highlight the value of the chordal replacement
concept.7
Kasegawa and associates11 reported similar results, with
a 12-year freedom from severe recurrent MR of 88% 3%
and a 90% 3% freedom fromMV-related reoperation af-
ter repair for AML prolapse. The vast majority of theirTABLE 1. Demographic data of all patients undergoing minimally
invasive mitral valve repair for anterior leaflet prolapse (n ¼ 170)
Age (y, mean  SD) 59.7  14.8
Male (no.) 97 (57.1%)
Preoperative NYHA functional class (mean  SD) 2.3  0.9
Logistic EuroSCORE (mean  SD) 4.9%  5.1%
Left ventricular ejection fraction (%, mean  SD) 61.2%  11.9%
Mean pulmonary arterial pressure (mm Hg,
mean  SD)
26.4  19.5
Atrial fibrillation (no.) 57 (33.5%)
Hypertension (no.) 94 (55.3%)
Diabetes mellitus (no.) 16 (9.4%)
Permanent pacemaker or AICD (no.) 13 (7.7%)
AICD, Automatic implantable cardioverter/defibrillator; NYHA, New York Heart
Association.
The Journal of Thoracic and Capatients (93%) were treated with polytetrafluoroethylene
sutures. Although these studies included patients undergo-
ing MV repair through a median sternotomy, Rodriguez
and coworkers13 showed a 91% 3-year freedom from
MV-related reoperation after robotic MV repair for AML
prolapse. This is of especial note because it proves the
adaptability of chordal replacement to the use of an intrao-
perative telemanipulator.
Alternative concepts to chordal replacement, however, do
exist. Long-term results after MV repair of AML prolapse
with the edge-to-edge repair and chordal transfer are prom-
ising as well. De Bonis and colleagues8 reported
a 96.6%  1.7% 5-year freedom from reoperation rate
for patients treated with a surgical edge-to-edge repair tech-
nique for AML prolapse. This is similar to the experience of
the Cleveland clinic with chordal transfer, reported in 2004
by Gillinov and colleagues10: they had a 5-year freedom
from reoperation after MV repair for AML prolapse of
96%.A1 segment
All patients (n ¼ 28) 1.9  1.0 22.0  3.0
Sex .04 .02
Male (n ¼ 23) 2.0  1.1 22.6  2.5
Female (n ¼ 5) 1.0  0.0 19.2  3.6
A2 segment
All patients (n ¼ 108) 3.0  1.2 21.0  3.3
Sex .6 <.01
Male (n ¼ 60) 3.1  1.3 22.0  3.2
Female (n ¼ 48) 2.9  1.0 20.3  3.3
A3 segment
All patients (n ¼ 51) 1.7  0.9 21.6  3.1
Sex .5 <.01
Male (n ¼ 35) 1.8  0.9 22.4  2.9
Female (n ¼ 21) 1.6  1.0 20.11  2.9
Data are mean  SD.
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FIGURE 3. Correlation between preoperative and predischarge echocar-
diographic studies. MR, Mitral regurgitation.
FIGURE 5. Postoperative survival of patients after mitral valve repair per-
formed with or without the loop technique.
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DIn contrast, chordal shortening is associated with worse
long-term results than either chordal replacement or
edge-to-edge repair. Phillips and coworkers22 published
a 98.6% freedom from reoperation at 3.5 postoperative
years after chordal replacement versus 85.2% after chordal
shortening. Smedira and associates23 reported a 5-year free-
dom from reoperation of 90% to 96% after chordal trans-
fer, compared with only 74% after chordal shortening.
Although repair of AML prolapse is traditionally consid-
ered to be more technically complex than repair of isolated
posterior mitral leaflet prolapse, our results confirm that pa-
tients with AML prolapse can be successfully treated withFIGURE 4. Freedom from mitral valve–related reoperation (MV-related
Re-Op) in patients undergoing mitral valve repair performed with or with-
out the loop technique.
112 The Journal of Thoracic and Cardiovascular Surga minimally invasive approach and the use of neochordal im-
plantation. As previously reported by our group,12,15,16 the
premeasured loop technique is a highly reproducible and
standardized method for MV repair. It was originally
developed to facilitate AML prolapse repair through
a minithoracotomy. Premeasured loops are available in
2-mm increments between 10 and 26mm in length.When ap-
plying this technique, the precise measurement of the loop
length is among the most challenging and most important
steps of the procedure. The data presented in this article offer
some guidance for surgeons adopting this technique. Espe-
cially, the mean lengths of loops used in our large series
may help other groups in reaching an optimal postoperative
result in these sometimes challengingAMLrepair operations.Study Limitations
The main limitation of this study is its retrospective na-
ture. It does, however, represent one of the largest series
to date of patients with isolated AML prolapse. We there-
fore believe that it is worth presenting. Another significant
limitation is the lack of long-term echocardiographic
follow-up data. This lack is due mainly to the fact that
well over a third of our patients undergoing MV repair are
referred from distant regions.CONCLUSIONS
AML prolapse can be safely and effectively treated
with minimally invasive MV repair, with good long-term
results.ery c July 2013
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